{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:03:50Z","timestamp":1792879430118,"version":"4.5.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088704","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T22:12:50Z","timestamp":1392329570000},"page":"e88704","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression"],"prefix":"10.1371","volume":"9","author":[{"given":"Akinobu","family":"Ochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koka","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187221411799015372","article-title":"Fetuin-A: a multifunctional protein","volume":"5","author":"K Mori","year":"2011","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-394317-0.00010-8","article-title":"Fetuin-A and the cardiovascular system","volume":"56","author":"K Mori","year":"2012","journal-title":"Adv Clin Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"N Stefan","year":"2013","journal-title":"Nat Rev Endcrinol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.29.02.06.dc05-1484","article-title":"Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects","volume":"29","author":"K Mori","year":"2006","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.300.2.182","article-title":"Fetuin-A and incident diabetes mellitus in older persons","volume":"300","author":"JH Ix","year":"2008","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"N Stefan","year":"2008","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0092-8674(89)90098-6","article-title":"Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity","volume":"58","author":"P Auberger","year":"1989","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"H Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/ATVBAHA.109.194050","article-title":"Saturated fatty acids do not directly stimulate Toll-like receptor signaling","volume":"29","author":"C Erridge","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"D Pal","year":"2012","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nm.3116","article-title":"Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans","volume":"19","author":"N Stefan","year":"2013","journal-title":"Nat Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2165\/11538100-000000000-00000","article-title":"Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents","volume":"70","author":"G Derosa","year":"2010","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.metabol.2008.04.019","article-title":"Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus","volume":"57","author":"K Mori","year":"2008","journal-title":"Metabolism"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-11-0864","article-title":"Fetuin-A in nonalcoholic fatty liver disease: in vivo and in vitro studies","volume":"166","author":"JW Haukeland","year":"2012","journal-title":"Eur J Endorinol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0021-9258(18)94242-0","article-title":"Tyrosine phosphorylayion of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells","volume":"264","author":"JM Backer","year":"1989","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2337\/db11-1116","article-title":"Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2","volume":"62","author":"M Monden","year":"2013","journal-title":"Diabetes"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2004.11.004","article-title":"Distinct Grb10 domain requirements for effects on glucose uptake and insulin signaling","volume":"230","author":"K Mori","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/jid.2009.423","article-title":"Overexpression of fetuin-a counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (abcc6(\u2212\/\u2212))","volume":"130","author":"Q Jiang","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"N Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of Disease: hepatic steatosis in type 2 diabetes\u2013pathogenesis and clinical relevance","volume":"2","author":"M Roden","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/BJ20100330","article-title":"NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance","volume":"429","author":"S Dasgupta","year":"2010","journal-title":"Biochem J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"T Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"A Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.ki.5002178","article-title":"Association of serum fetuin-A levels with mortality in dialysis patients","volume":"72","author":"MM Hermans","year":"2007","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M210868200","article-title":"Structural basis of calcification inhibition by alpha 2-HS glycoprotein\/fetuin-A. Formation of colloidal calciprotein particles","volume":"278","author":"A Heiss","year":"2003","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"O Gavrilova","year":"2003","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"K Matsusue","year":"2003","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.5551\/jat.No950","article-title":"High gluose induces transactivation of the a2-HS glycoprotein gene through the ERK1\/2 signaling pathway","volume":"16","author":"H Takata","year":"2009","journal-title":"J Atheroscler Thromb"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T15:17:38Z","timestamp":1648307858000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088704"}},"subtitle":[],"editor":[{"given":"Jean-Marc A.","family":"Lobaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088704","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}